Abstract:Cold atmospheric plasma emerges as a cancer therapy that can activate and enhance anti‐tumor immune responses through different mechanisms. This ensures durable and systemic therapeutic effects. This review presents a comprehensive summary of immune‐response promoting mechanisms of plasma therapy, the limitations of current plasma modalities, and cutting‐edge developments in plasma‐treated hydrogels as a novel, minimally‐invasive modality to treat non‐surface tumors. Cold atmospheric plasma (CAP) is a partially ionized gas that gains attention as a well‐tolerated cancer treatment that can enhance anti‐tumor immune responses, which are important for durable therapeutic effects. This review offers a comprehensive and critical summary on the current understanding of mechanisms in which CAP can assist anti‐tumor immunity: induction of immunogenic cell death, oxidative post‐translational modifications of the tumor and its microenvironment, epigenetic regulation of aberrant gene expression, and enhancement of immune cell functions. This should provide a rationale for the effective and meaningful clinical implementation of CAP. As discussed here, despite its potential, CAP faces different clinical limitations associated with the current CAP treatment modalities: direct exposure of cancerous cells to plasma, and indirect treatment through injection of plasma‐treated liquids in the tumor. To this end, a novel modality is proposed: plasma‐treated hydrogels (PTHs) that can not only help overcome some of the clinical limitations but also offer a convenient platform for combining CAP with existing drugs to improve therapeutic responses and contribute to the clinical translation of CAP. Finally, by integrating expertise in biomaterials and plasma medicine, practical considerations and prospective for the development of PTHs are offered.

Clinical application of cold atmospheric-pressure plasma: mechanisms and irradiation conditions

Cold atmospheric plasma applications in dermatology: A systematic review

Cold Atmospheric Plasma: An Emerging Immunomodulatory Therapy

Cold atmospheric plasma (CAP): a revolutionary approach in dermatology and skincare

Preclinical Cold Atmospheric Plasma Cancer Treatment

Cold Atmospheric Pressure Plasmas in Dermatology: Sources, Reactive Agents, and Therapeutic Effects

Plasma Dermatology: Skin Therapy Using Cold Atmospheric Plasma

Plasma Medicine and The Application in Tumor Therapy

Intracellular Responses Triggered by Cold Atmospheric Plasma and Plasma-Activated Media in Cancer Cells

Current State of Cold Atmospheric Plasma and Cancer‐Immunity Cycle: Therapeutic Relevance and Overcoming Clinical Limitations Using Hydrogels

Therapeutic Effects of Cold Atmospheric Plasma on Solid Tumor

Medical Applications of Nonthermal Atmospheric Pressure Plasma in Dermatology

Cold Atmospheric Plasma Ameliorates Skin Diseases Involving Reactive Oxygen/Nitrogen Species-Mediated Functions

Cold atmospheric plasma delivery for biomedical applications

Principles of using Cold Atmospheric Plasma Stimulated Media for Cancer Treatment

Plasma Control: A Review of Developments and Applications of Plasma Medicine Control Mechanisms

Design considerations of cold atmospheric plasma sources for treatment of living tissues

[Mechanism of cold atmospheric plasma in treatment of chronic skin ulcer]

Medical applications of nonthermal atmospheric pressure plasma in dermatology.

Cold Physical Plasma Modulates p53 and Mitogen-Activated Protein Kinase Signaling in Keratinocytes

Advantages of Cold Atmospheric Plasma Jet Generated by Positive Pulse Voltage in Anti-Cancer Therapy